Title of article
gut microbial signature and gut-lung axis: a possible role in the therapy of covid-19
Author/Authors
mahmoodpoor, ata tabriz university of medical sciences - faculty of medicine - anesthesiology and critical care department, tabriz, iran , shamekh, ali tabriz university of medical sciences - student research committee, tabriz, iran , sanaie, sarvin tabriz university of medical sciences - neurosciences research center, aging research institute, tabriz, iran
From page
175
To page
177
Abstract
the impact of gut as the origin of different disorders has led to the gut-origin concept of diseases. the gut microbiome regulates host defenses against viral infections, thus dysbiosis can play a major role in triggering the cascade of inflammation and causing immune imbalances in covid-19 patients. it appears that gut microbial signature in covid-19 patients can be used as a potential diagnostic, therapeutic, and even a prognostic marker. personalized nutrition therapy can be used by profiling the gut microbiota of individual patients and specialized probiotics/synbiotics to modify gut dysbiosis. hence, improving overall immune responses can be recommended in these patients
Keywords
gut microbiota , probiotics , gut lung axis , covid , 19
Journal title
Bioimpacts
Journal title
Bioimpacts
Record number
2704665
Link To Document